Hematopoietic stem cell transplantation in juvenile myelomonocytic leukemia: analyse one centre experience and literature review
Allogeneic hematopoietic stem cell transplantation (HSCT) is the standard curative therapy for juvenile myelomonocytic leukemia (JMML). Seventeen patients with JMML received myeloablative conditioning (busulfan-based — 15, treosulfan-based — 2). Donors included 5 matched related siblings, 8 — matche...
Saved in:
| Main Authors: | M. A. Maschan, L. A. Khachatryan, Yu. V. Skvortsova, E. E. Kurnikova, D. A. Shasheleva, V. O. Bobrynina, D. N. Balashov, E. V. Skorobogatova, D. D. Baydildina, G. A. Novichkova, A. A. Maschan |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/105 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Results of differential treatment of children with juvenile myelomonocytic leukemia with 13-cis retinoic acid and low dose cytosine-arabinoside
by: L. A. Khachatrian, et al.
Published: (2022-11-01) -
Risk factors of cytomegalovirus infection in patients after allogeneic hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01) -
Late non-infectious lung damage in children after allogeneic hematopoietic stem cells transplantation
by: Yu. V. Skvortsova, et al.
Published: (2015-06-01) -
Juvenile Myelomonocytic Leukemia in a Premature Neonate Mimicking Neonatal Sepsis
by: Ming-Luen Lee, et al.
Published: (2016-04-01) -
Use of plerixafor for hematopoietic stem cells mobilization in allograft donors
by: D. N. Balashov, et al.
Published: (2015-01-01)